Clinical Trial Results:
Etude randomisée, en double insu et multicentrique de l'association Interferon pégylé alpha 2b-Ribavirine versus l'association Interferon pégylé alpha 2b-placebo dans le traitement au long cours (3 ans) de la fibrose hépatique chez les patients non répondeurs ayant une hépatite virale chronique C.
Summary
|
|
EudraCT number |
2005-002937-11 |
Trial protocol |
BE |
Global completion date |
31 Mar 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
28 Mar 2023
|
First version publication date |
28 Mar 2023
|
Other versions |
|
Summary report(s) |
Summary of Final report |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.